EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Burden of perianal disease in Crohn's disease: Accelerating medical therapy and high rates of perianal surgery over the last four decades – Results from a population‐based study over four decades

Lorant Gonczi, Laszlo Lakatos, Petra A Golovics, Dorottya Angyal, Fruzsina Balogh, Akos Ilias, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita, Peter L Lakatos iD

Alimentary Pharmacology & Therapeutics · 2024-03 · 59 (5) · 656-665

DOI: 10.1111/apt.17836 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 19.12.2023. Verfasst von Lorant Gonczi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary. Hauptthemen laut MEDLINE: Crohn Disease, Rectal Fistula. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: ÚNKP-23-4-II-SE-20 New National Excellence Program of the Ministry for Culture and Innovation, Source of the National Research, Development and Innovation Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Few population‐based studies have investigated the prevalence and disease course of perianal manifestation in Crohn's disease.

Aims

To analyse the prevalence and outcomes of perianal Crohn's disease including medical therapies and need for perianal surgery, over different therapeutic eras based on the time of diagnosis; cohort A (1977–1995), cohort B (1996–2008), and cohort C (2009–2018)

Methods

Patient inclusion lasted between 1977 and 2018. We followed patients prospectively, and regularly reviewed both in‐hospital and outpatient records. We defined a perianal surgical procedure as any perianal incision and excision, fistulotomy, or abscess drainage.

Results

We included 946 incident patients. Perianal disease at diagnosis was present in 17.4% ( n = 165) of the total cohort, with a declining prevalence in cohorts A/B/C, respectively (24.7%/18.5%/13.2%; p = 0.001). By the end of follow‐up, an additional 9.3% ( n = 88) of the total cohort developed perianal disease. Cumulative immunosuppressive and biologic exposure increased over time; biologic use was higher in patients with perianal disease [ p Log Rank < 0.001]. The overall rate of perianal surgery was 44.7% (113/253), with a probability of 28.3% (95% CI: 25.4–31.2) after 10 years, 41.0% (95% CI: 37.5–44.5) after 20 years, and 64.1% (95% CI: 59–69.2) after 30 years. There was no statistically significant difference in the probability of first perianal surgery among cohorts A/B/C [Log Rank = 0.594].

Conclusions

The burden of perianal disease and perianal surgery rates were high in this cohort. Therapeutic strategy was accelerated in patients with perianal Crohn's over time with higher exposure to immunosuppressives and biologics. Surgical management of perianal disease remained unchanged amongst the cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseRectal FistulaHumansFollow-Up StudiesImmunosuppressive AgentsDisease ProgressionDrainageTreatment Outcome

Stichwörter der Autor:innen

Crohn’s diseasebiologicalsperianal diseaseperianal surgerypopulation-based

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.
  • Department of Gastroenterology, Ferenc Csolnoky Hospital, Veszprem, Hungary.
  • Department of Gastroenterology, Hungarian Defence Forces Medical Centre, Budapest, Hungary.
  • Department of Gastroenterology, Grof Eszterhazy Hospital, Papa, Hungary.
  • Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Canada.

ORCID-Profile: Peter L Lakatos

Förderung

  • ÚNKP-23-4-II-SE-20 New National Excellence Program of the Ministry for Culture and Innovation
  • Source of the National Research, Development and Innovation Fund

Zitieren

APA

Gonczi, L., Lakatos, L., Golovics, P. A., Angyal, D., Balogh, F., Ilias, A., Pandur, T., David, G., Erdelyi, Z., Szita, I., & Lakatos, P. L. (2024). Burden of perianal disease in Crohn's disease: Accelerating medical therapy and high rates of perianal surgery over the last four decades – Results from a population‐based study over four decades. Alimentary Pharmacology & Therapeutics, 59(5), 656-665. https://doi.org/10.1111/apt.17836

Vancouver

Gonczi L, Lakatos L, Golovics PA, Angyal D, Balogh F, Ilias A, et al. Burden of perianal disease in Crohn's disease: Accelerating medical therapy and high rates of perianal surgery over the last four decades – Results from a population‐based study over four decades. Alimentary Pharmacology & Therapeutics. 2024;59(5):656-665. doi:10.1111/apt.17836

BibTeX
@article{Gonczi2024,
  author = {Gonczi, Lorant and Lakatos, Laszlo and Golovics, Petra A and Angyal, Dorottya and Balogh, Fruzsina and Ilias, Akos and Pandur, Tunde and David, Gyula and Erdelyi, Zsuzsanna and Szita, Istvan and Lakatos, Peter L},
  title = {Burden of perianal disease in Crohn's disease: Accelerating medical therapy and high rates of perianal surgery over the last four decades – Results from a population‐based study over four decades},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2024},
  volume = {59},
  number = {5},
  pages = {656--665},
  doi = {10.1111/apt.17836}
}
Kostenlos starten →